Patents by Inventor Beatrice Beck-Schimmer

Beatrice Beck-Schimmer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bioconjugates of antibodies and functionalized magnetic nanoparticles
    Patent number: 11827721
    Abstract: The present invention relates to the field of antibodies useful in therapy and diagnosis. It specifically discloses bioconjugates comprising one or more antibodies bound to functionalized, magnetic nanoparticles. These bioconjugates are useful in cancer therapy, particularly for removing circulating tumor cells. The invention further pertains to specific functionalized, magnetic nanoparticles and to the manufacturing of such bioconjugates and such functionalized, magnetic nanoparticles.
    Type: Grant
    Filed: February 25, 2019
    Date of Patent: November 28, 2023
    Assignee: Universität Zürich and ETH Zurich
    Inventors: Antoine Florent Herzog, Wendelin Jan Stark, Martin Zeltner, Beatrice Beck-Schimmer, Anja Zabel
  • OXYGEN/CARBON DIOXIDE COMPOSITIONS FOR MEDICAL USES
    Publication number: 20230070984
    Abstract: The present invention relates to compositions comprising gases, particularly oxygen (O2) in an amount of from about 91% to about 99% by volume, and carbon dioxide (CO2) in an amount of from about 1% to about 9% by volume, based upon the total volume of the composition, and their use in mitigating the negative effects of surgery and/or anaesthesia on a patient.
    Type: Application
    Filed: February 18, 2021
    Publication date: March 9, 2023
    Applicants: AVIATION WORKS LIMITED, UNIVERSITY OF ZURICH
    Inventors: Marc STUDER, Simisola OKE, Rob BOYLE, Beatrice Beck SCHIMMER, Martin SCHLÄPFER
  • Bioconjugates of Antibodies and Fuctionalized Magnetic Nanoparticles
    Publication number: 20200399401
    Abstract: The present invention relates to the field of antibodies useful in therapy and diagnosis. It specifically discloses bioconjugates comprising one or more antibodies bound to functionalized, magnetic nanoparticles. These bioconjugates are useful in cancer therapy, particularly for removing circulating tumor cells. The invention further pertains to specific functionalized, magnetic nanoparticles and to the manufacturing of such bioconjugates and such functionalized, magnetic nanoparticles.
    Type: Application
    Filed: February 25, 2019
    Publication date: December 24, 2020
    Applicants: Universität Zürich, ETH Zurich
    Inventors: Antoine Florent Herzog, Wendelin Jan Stark, Martin Zeltner, Beatrice Beck-Schimmer, Anja Zabel
  • Injectable formulation for treatment and protection of patients having an Inflammatory Reaction or an Ischemia-reperfusion event
    Patent number: 9296678
    Abstract: The present invention relates to compounds according to formula (I) for medical use. The compounds are particularly suitable for the treatment and/or prevention of a medical condition involving hypoxic, anoxic and/or inflamed mammalian tissue. Furthermore, the invention relates to the use of said compounds for preparing a medicament and to pharmaceutical preparations comprising such compounds. The invention also relates to methods of treating or protecting patients having or being prone to develop a medical condition involving hypoxic, anoxic and/or inflamed mammalian tissue, the methods comprising administration of a therapeutically effective amount of such compounds.
    Type: Grant
    Filed: December 11, 2013
    Date of Patent: March 29, 2016
    Assignees: UNIVERSITY OF ZURICH, ETH ZURICH
    Inventors: Ludwig K. Limbach, Inge K. Herrmann, Beatrice Beck-Schimmer, Wendelin J. Stark, Martin Urner
  • Injectable Formulation for Treatment and Protection of Patients Having an Inflammatory Reaction or an Ischemia-Reperfusion Event
    Publication number: 20140100278
    Abstract: The present invention relates to compounds according to formula (I) for medical use. The compounds are particularly suitable for the treatment and/or prevention of a medical condition involving hypoxic, anoxic and/or inflamed mammalian tissue. Furthermore, the invention relates to the use of said compounds for preparing a medicament and to pharmaceutical preparations comprising such compounds. The invention also relates to methods of treating or protecting patients having or being prone to develop a medical condition involving hypoxic, anoxic and/or inflamed mammalian tissue, the methods comprising administration of a therapeutically effective amount of such compounds.
    Type: Application
    Filed: December 11, 2013
    Publication date: April 10, 2014
    Applicants: ETH ZURICH, UNIVERSITY OF ZURICH
    Inventors: Ludwig K. Limbach, Inge K. Herrmann, Beatrice Beck-Schimmer, Wendelin J. Stark, Martin Urner
  • INJECTABLE FORMULATION FOR TREATMENT AND PROTECTION OF PATIENTS HAVING AN INFLAMMATORY REACTION OR AN ISCHEMIA-REPERFUSION EVENT
    Publication number: 20120219596
    Abstract: Compounds according to formula (I) are particularly suitable for the treatment and/or prevention of a medical condition involving hypoxic, anoxic and/or inflamed mammalian tissue. Furthermore, the invention relates to the use of said compounds for preparing a medicament and to pharmaceutical preparations comprising such compounds.
    Type: Application
    Filed: July 27, 2010
    Publication date: August 30, 2012
    Applicants: ETH Zurich, University of Zurich
    Inventors: Ludwig K. Limbach, Inge K. Herrmann, Beatrice Beck-Schimmer, Wendelin J. Stark, Martin Urner